The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses
Open accessAbstract
Inhibitors of the protease of HIV-1 have been used successfully for the treatment of HIV-1-infected patients and AIDS disease. We tested whether these protease inhibitory drugs exerted effects in addition to their antiviral activity. Here, we show in mice infected with lymphocytic choriomeningitis virus and treated with the HIV-1 protease inhibitor ritonavir a marked inhibition of antiviral cytotoxic T lymphocyte (CTL) activity and impaired major histocompatibility complex class I-restricted epitope presentation in the absence of direct effects on lymphocytic choriomeningitis virus replication. A potential molecular target was found: ritonavir selectively inhibited the chymotrypsin-like activity of the 20S proteasome. In view of the possible role of T cell-mediated immunopathology in AIDS pathogenesis, the two mechanisms of action (i.e., reduction of HIV replication and impairment of CTL responses) may complement each other beneficially. Thus, the surprising ability of ritonavir to block the presentation of antigen to CTLs may possibly contribute to therapy of HIV infections but potentially also to the therapy of virally induced immunopathology, autoimmune diseases, and transplantation reactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure of 20S proteasome from yeast at 2.4Å resolution
Groll, M., Ditzel, L., Löwe, J., Stock, D., Bochtler, M., Bartunik, H. D., & Huber, R. (1997) · Nature · doi:10.1038/386463a0 · Cited by 2,257
Zinkernagel, R. M., & Doherty, P. C. (1979) · Advances in Immunology · doi:10.1016/s0065-2776(08)60262-x · Cited by 1,933
Self-citationVigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia
Rosenberg, E. S., Billingsley, J. M., Caliendo, A. M., Boswell, S. L., Sax, P. E., Kalams, S. A., & Walker, B. D. (1997) · Science · doi:10.1126/science.278.5342.1447 · Cited by 1,835
Autran, B., Carcelain, G., Li, T. S., Blanc, C., Mathez, D., Tubiana, R., Katlama, C., Debré, P., & Leibowitch, J. (1997) · Science · doi:10.1126/science.277.5322.112 · Cited by 1,785
Kawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P. F., Rivoltini, L., Yannelli, J. R., Appella, E., & Rosenberg, S. A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.347 · Cited by 862
Bais, C., Santomasso, B., Coso, O., Arvanitakis, L., Raaka, E. G., Gutkind, J. S., Asch, A. S., Cesarman, E., Gerhengorn, M. C., & Mesri, E. A. (1998) · Nature · doi:10.1038/34193 · Cited by 829
Danner, S. A., Carr, A., Leonard, J. M., Lehman, L. M., Gudiol, F., Gonzales, J., Raventos, A., Rubio, R., Bouza, E., Pintado, V., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512073332303 · Cited by 567
Kempf, D. J., Marsh, K. C., Denissen, J. F., McDonald, E., Vasavanonda, S., Flentge, C. A., Green, B. E., Fino, L., Park, C. H., & Kong, X. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2484 · Cited by 560
The Virology and Immunobiology of Lymphocytic Choriomeningitis Virus Infection
Buchmeier, M. J., Welsh, R. M., Dutko, F. J., & Oldstone, M. B. A. (1980) · Advances in Immunology · doi:10.1016/s0065-2776(08)60197-2 · Cited by 545
Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease
Cameron, D. W., Heath-Chiozzi, M., Danner, S., Cohen, C., Kravcik, S., Maurath, C., Sun, E., Henry, D., Rode, R., Potthoff, A., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)04161-5 · Cited by 536
Battegay, M., Cooper, S., Althage, A., Bänziger, J., Hengartner, H., & Zinkernagel, R. M. (1991) · Journal of Virological Methods · doi:10.1016/0166-0934(91)90018-u · Cited by 475
Self-citationCytomegalovirus retinitis after initiation of highly active antiretroviral therapy
Jacobson, M. A., Zegans, M., Pavan, P. R., O'Donnell, J. J., Sattler, F., Rao, N., Owens, S., & Pollard, R. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11431-8 · Cited by 366
Fibroblasts as Efficient Antigen-Presenting Cells in Lymphoid Organs
Kündig, T. M., Bachmann, M. F., DiPaolo, C., Simard, J. J. L., Battegay, M., Lother, H., Gessner, A., Kühlcke, K., Ohashi, P. S., Hengartner, H., et al. (1995) · Science · doi:10.1126/science.7761853 · Cited by 301
Self-citationThe Role of Antibody Concentration and Avidity in Antiviral Protection
Bachmann, M. F., Kalinke, U., Althage, A., Freer, G., Burkhart, C., Roost, H.-P., Aguet, M., Hengartner, H., & Zinkernagel, R. M. (1997) · Science · doi:10.1126/science.276.5321.2024 · Cited by 267
Self-citationGroettrup, M., Ruppert, T., Kuehn, L., Seeger, M., Standera, S., Koszinowski, U., & Kloetzel, P. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23808 · Cited by 228
Self-citationPeptide antigen production by the proteasome: complexity provides efficiency
Groettrup, M., Soza, A., Kuckelkorn, U., & Kloetzel, P.-M. (1996) · Immunology Today · doi:10.1016/0167-5699(96)10051-7 · Cited by 221
Self-citationHIV Treatment Failure: Testing for HIV Resistance in Clinical Practice
Perrin, L., & Telenti, A. (1998) · Science · doi:10.1126/science.280.5371.1871 · Cited by 193
Carr, A., & Cooper, D. A. (1997) · The Lancet · doi:10.1016/s0140-6736(05)62892-9 · Cited by 169
Cerundolo, V., Benham, A. M., Braud, V. M., Mukherjee, S., Gould, K. G., Macino, B., Neefjes, J., & Townsend, A. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270148 · Cited by 132
Self-citationGervois, N., Guilloux, Y., Diez, E., & Jotereau, F. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.5.2403 · Cited by 122
Self-citationSpecific cytotoxic T cells eliminate cells producing neutralizing antibodies
Planz, O., Seiler, P. J., Hengartner, H., & Zinkernagel, R. M. (1996) · Nature · doi:10.1038/382726a0 · Cited by 83
Self-citationAntón, L. C., Snyder, H. L., Bennink, J. R., Vinitsky, A., Orłowski, M., Porgador, A., & Yewdell, J. W. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.4859 · Cited by 65
Characterization of virus‐specific cytotoxic T cell clones from allogeneic bone marrow chimeras
Pircher, H., Baenziger, J., Schilham, M. W., Sado, T., Kamisaku, H., Hengartner, H., & Zinkernagel, R. M. (1987) · European Journal of Immunology · doi:10.1002/eji.1830170202 · Cited by 58
Self-citationKlenerman, P., & Zinkernagel, R. M. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb01003.x · Cited by 36
Self-citation
Cited by
Strategies for MMP inhibition in cancer: innovations for the post-trial era
Overall, C. M., & López-Otín, C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc884 · Cited by 1,349
The proteasome: a suitable antineoplastic target
Adams, J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1361 · Cited by 1,201
Dubé, M. P., Stein, J. H., Aberg, J. A., Fichtenbaum, C. J., Gerber, J. G., Tashima, K. T., Henry, W. K., Currier, J. S., Sprecher, D., Glesby, M. J., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/378131 · Cited by 580
Dantuma, N. P., Lindsten, K., Glas, R., Jellne, M., & Masucci, M. G. (2000) · Nature Biotechnology · doi:10.1038/75406 · Cited by 553
Dendritic cells: emerging pharmacological targets of immunosuppressive drugs
Hackstein, H., & Thomson, A. W. (2004) · Nature Reviews Immunology · doi:10.1038/nri1256 · Cited by 545
Metadata
- Authors
- André, P., Groettrup, M., Klenerman, P., de Giuli, R., Booth, B. L., Cerundolo, V., Bonneville, M., Jotereau, F., Zinkernagel, R. M., & Lotteau, V.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1998-10-27
- Volume
- 95
- Issue
- 22
- Pages
- 13120-13124
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2024789710
- Cited by
- 279
- References
- 24
- FWCI
- 5.22
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.